Inflammation in acute and chronic pancreatitis

Current Opinion in Gastroenterology

Volumn 31, Issue 5, 2015, Pages 395-399

  Habtezion, Aida ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute pancreatitis; Chronic pancreatitis; High mobility group box 1; Macrophages; Toll like receptor

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 33; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; PATHOGEN ASSOCIATED MOLECULAR PATTERN;

ACINAR CELL; ACUTE PANCREATITIS; CELL INTERACTION; CHRONIC PANCREATITIS; DISEASE COURSE; DISEASE SEVERITY; FIBROGENESIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS NECROSIS; PANCREATIC STELLATE CELL; REVIEW; ACUTE DISEASE; ANIMAL; DISEASE MODEL; FECAL MICROBIOTA TRANSPLANTATION; IMMUNOLOGY; METABOLISM; PANCREAS; PANCREATITIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TRENDS;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; INFLAMMATION; PANCREAS; PANCREATITIS; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84942525569     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000195     Document Type: Review

References (58)

1. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012; 143:1179-1187.
2. Nojgaard C, Becker U, Matzen P, et al. Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course. Pancreas 2011; 40:1195-1200.
3. Yadav D, O'Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol 2012; 107:1096-1103.
4. Braganza JM, Lee SH, McCloy RF, et al. Chronic pancreatitis. Lancet 2011; 377:1184-1197.
5. Witt H, Apte MV, Keim V, et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007; 132:1557-1573.
6. Zheng L, Xue J, Jaffee EM, et al. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology 2013; 144:1230-1240.
7. Mayer J, Rau B, Gansauge F, et al. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47:546-552.
8. Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995; 130:966-970.
9. Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 1997; 100:1853-1862.
10. Gu H, Werner J, Bergmann F, et al. Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis. Cell Death Dis 2013; 4:e816.
11. Gukovskaya AS, Vaquero E, Zaninovic V, et al. Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 2002; 122:974-984.
12. Abdulla A, Awla D, Thorlacius H, et al. Role of neutrophils in the activation of trypsinogen in severe acute pancreatitis. J Leukoc Biol 2011; 90:975-982.
13. Oiva J, Mustonen H, Kylanpaa ML, et al. Patients with acute pancreatitis complicated by organ dysfunction show abnormal peripheral blood polymorphonuclear leukocyte signaling. Pancreatology 2013; 13:118-124.
14. Montecucco F, Mach F, Lenglet S, et al. Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis. Eur J Clin Invest 2014; 44:940-950.
15. Zhang H, Neuhofer P, Song L, et al. IL-6 trans-signaling promotes pancreatitis- associated lung injury and lethality. J Clin Invest 2013; 123:1019-1031.
16. Scheller J, Garbers C, Rose-John S. Interleukin-6: frombasic biology to selective blockade of pro-inflammatory activities. Semin Immunol 2014; 26:2-12.
17. Garbers C, Scheller J. Interleukin-6 and interleukin-11: same same but different. Biol Chem 2013; 394:1145-1161.
18. Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 2011; 121:3375-3383.
19. Folias AE, Penaranda C, Su AL, et al. Aberrant innate immune activation following tissue injury impairs pancreatic regeneration. PLoS One 2014; 9:e102125.
20. Liou GY, Doppler H, Necela B, et al. Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-kappaB and MMPs. J Cell Biol 2013; 202:563-577.
21. Criscimanna A, Coudriet GM, Gittes GK, et al. Activated macrophages create lineage-specific microenvironments for pancreatic acinar- and beta-cell regeneration in mice. Gastroenterology 2014; 147:1106-1118.
22. Petrov MS, Shanbhag S, Chakraborty M, et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology 2010; 139:813-820.
23. Choudhry MA, Rana SN, Kavanaugh MJ, et al. Impaired intestinal immunity and barrier function: a cause for enhanced bacterial translocation in alcohol intoxication and burn injury. Alcohol 2004; 33:199-208.
24. Thandassery RB, Yadav TD, Dutta U, et al. Hypotension in the first week of acute pancreatitis and APACHE II score predict development of infected pancreatic necrosis. Dig Dis Sci 2015; 60:537-542.
25. Guo ZZ, Wang P, Yi ZH, et al. The crosstalk between gut inflammation and gastrointestinal disorders during acute pancreatitis. Curr Pharm Des 2014; 20:1051-1062.
26. Sharif R, Dawra R, Wasiluk K, et al. Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut 2009; 58:813-819.
27. Awla D, Abdulla A, Regner S, et al. TLR4 but not TLR2 regulates inflammation and tissue damage in acute pancreatitis induced by retrograde infusion of taurocholate. Inflamm Res 2011; 60:1093-1098.
28. Hoque R, Farooq A, Ghani A, et al. Lactate reduces liver and pancreatic injury in toll-like receptor- and inflammasome-mediated inflammation via GPR81- mediated suppression of innate immunity. Gastroenterology 2014; 146: 1763-1774.
29. Xue J, Habtezion A. Carbon monoxide-based therapy ameliorates acute pancreatitis via TLR4 inhibition. J Clin Invest 2014; 124:437-447.
30. Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Opin Genet Dev 2003; 13:170-178.
31. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191-195.
32. Kang R, Zhang Q, Hou W, et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology 2014; 146:1097-1107.
33. Miyake Y, Yamasaki S. Sensing necrotic cells. Adv Exp Med Biol 2012; 738:144-152.
34. Tian J, Avalos AM, Mao SY, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8:487-496.
35. Yasuda T, Ueda T, Takeyama Y, et al. Significant increase of serum highmobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 2006; 33:359-363.
36. Kocsis AK, Szabolcs A, Hofner P, et al. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis. Pancreatology 2009; 9:383-391.
37. Carriere V, Roussel L, Ortega N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 2007; 104:282-287.
38. Miller AM. Role of IL-33 in inflammation and disease. J Inflamm (Lond) 2011; 8:22.
39. Gadina M, Jefferies CA. IL-33: a sheep in wolf's clothing? Sci STKE 2007; 2007:e31.
40. Schiering C, Krausgruber T, Chomka A, et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014; 513:564-568.
41. Ouziel R, Gustot T, Moreno C, et al. The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice. Am J Pathol 2012; 180:2330-2339.
42. Kempuraj D, Twait EC, Williard DE, et al. The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice. PLoS One 2013; 8:e56866.
43. Sesti-Costa R, Silva GK, Proenca-Modena JL, et al. The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis. J Immunol 2013; 191:283-292.
44. Haraldsen G, Balogh J, Pollheimer J, et al. Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol 2009; 30:227-233.
45. Apte MV, Pirola RC, Wilson JS. Pancreatic stellate cells: a starring role in normal and diseased pancreas. Front Physiol 2012; 3:344.
46. Emmrich J, Weber I, Nausch M, et al. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Digestion 1998; 59:192-198.
47. Goecke H, Forssmann U, Uguccioni M, et al. Macrophages infiltrating the tissue in chronic pancreatitis express the chemokine receptor CCR5. Surgery 2000; 128:806-814.
48. Deng X, Wang L, Elm MS, et al. Chronic alcohol consumption accelerates fibrosis in response to cerulein-induced pancreatitis in rats. Am J Pathol 2005; 166:93-106.
49. Hunger RE, Mueller C, Z'Graggen K, et al. Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology 1997; 112:1656-1663.
50. Schmitz-Winnenthal H, Pietsch DH, Schimmack S, et al. Chronic pancreatitis is associated with disease-specific regulatory T-cell responses. Gastroenterology 2010; 138:1178-1188.
51. Detlefsen S, Sipos B, Feyerabend B, et al. Fibrogenesis in alcoholic chronic pancreatitis: the role of tissue necrosis, macrophages, myofibroblasts and cytokines. Mod Pathol 2006; 19:1019-1026.
52. Deng X, Wang L, Elm MS, et al. Chronic alcohol consumption accelerates fibrosis in response to cerulein-induced pancreatitis in rats. Am J Pathol 2005; 166:93-106.
53. Xue J, Sharma V, Hsieh MH, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun 2015; 6:7158.
54. Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 2012; 61:582-588.
55. Leppkes M, Nowecki S, Wirtz SJ, et al. Intestinal microbiota contributes to the pathogenesis of IL-17A induced chronic pancreatitis. Gastroenterology 2014; 146:S-68.
56. Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44:354-360.
57. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44:551-561.
58. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized, controlled trial. Gastroenterology 2015. [Epub ahead of print]